Results 91 to 100 of about 361,079 (214)

Pneumococcal conjugate vaccine use in adults

Expert Review of Vaccines, 2015
Streptococcus pneumoniae is a leading cause of illness and death in adults. A polysaccharide vaccine has been available for over 30 years, but despite significant use, the public health impact of this vaccine has been limited. The 13-valent pneumococcal conjugate vaccine (PCV13) has been licensed by the US Food and Drug Administration and other ...
Raul E. Isturiz, Beate Schmoele-Thoma, Daniel A. Scott, Luis Jodar, Chris Webber, Heather L. Sings, Peter Paradiso   +6 more
openaire   +2 more sources

Can hexavalent vaccines be simultaneously administered with pneumococcal or meningococcal conjugate vaccines?

, 2007
Background: Local immunization programs may include hexavalent and conjugate pneumococcal or meningococcal vaccines administered in the same vaccination visit.
Bartolozzi G., Aizari C., Esposito S., Giudice M. L., Fara G. M., Tozzi A. E.   +5 more
core   +1 more source

Efficacy of an 11-Valent Pneumococcal Conjugate Vaccine Against Radiologically Confirmed Pneumonia Among Children Less Than 2 Years of Age in the Philippines A Randomized, Double-Blind, Placebo-Controlled Trial

, 2009
Background: Pneumococcus is a leading cause of childhood pneumonia worldwide. Pneumococcal Conjugate vaccines (PCV) have demonstrated efficacy against childhood invasive pneumococcal disease (IPD) and pneumonia in the United States and Africa.
Sombrero, Lydia, Abucejo-Ladesma, Erma, Ruutu, Petri, Simoes, Eric A. F., Lechago, Marites, Soininen, A, de Campo, M, Lucero, Marilla G., Forsyth, Simon, Makela, HP, Ruutu, P, Nissinen, Antti, Puumalainen, T, Abucejo-Ladesma, E, Ugpo, J, Sombrero, L, Riley, Ian, Puumalainen, Taneli, Williams, Gail, Lechago, M, Lucero, MG, Sanvictores, Diozele, de Campo, Margaret, Simoes, EAF, Lupisan, Socorro, Lupisan, S, Riley, I, Tallo, V, Tallo, Veronica, Ugpo, Juanita, Soininen, Anu, Nohynek, Hanna, Sanvictores, D, Makela, Helen P., Nohynek, H, Williams, G, Forsyth, S, Nissinen, A   +37 more
core   +1 more source

Recommendations and guidance for pneumococcal vaccination for adults in Taiwan

Journal of Microbiology, Immunology and Infection
Streptococcus pneumoniae remains a global health concern, causing diseases from sinusitis, otitis media, to invasive pneumococcal diseases (IPD), such as bacteremia, bacteremic pneumonia, empyema, and meningitis.
I-Fan Lin, Kuan-Yin Lin, Lian-Yi Su, Wei-Hsuan Huang, Wen-Chia Tsai, Ping-Feng Wu, Ching-Hsun Wang, Chia-Hsiang Yu, Miao-Chiu Hung, Cheng-Hsun Chiu, Chien-Hsien Huang, Nan-Chang Chiu, Chun-Yi Lu, Ming-Fang Cheng, Szu-Min Hsieh, Ning-Chi Wang, Ping-Ing Lee, Hsiao-Wei Wang, Swee Siang Wong, Po-Chang Lin, Ming-Han Tsai, Shun-Cheng Yang, Yu-Lung Hsu, Chuen-Sheue Chiang, Susan Shin-Jung Lee, Yee-Chun Chen, Feng-Yee Chang   +26 more
doaj   +1 more source

Approaches to vaccination of adults against pneumococcal disease in different countries of the world

Журнал инфектологии
Various pneumococcal vaccines are available worldwide, differing in the range of serotypes coverage and type of vaccine, which determine different mechanisms of action and postvaccinal immunity. Vaccination  against  pneumococcal infection is recommended
A. S. Korovkin, Yu. I. Obukhov, E. N. Syatchikhina   +2 more
doaj   +1 more source

Serotype distribution in non-bacteremic pneumococcal pneumonia:association with disease severity and implications for pneumococcal conjugate vaccines

, 2013
There is limited knowledge of serotypes that cause non-bacteremic pneumococcal pneumonia (NBP). Here we report serotypes, their associated disease potential and coverage of pneumococcal conjugate vaccines (PCV) in adults with NBP and compare these to ...
Helle Bossen Konradsen, Schønheyder, Henrik Carl, Lambertsen, Lotte, Thomas Benfield, Reimar Wernich Thomsen, Skovgaard, Marlene, Bangsborg, Jette, Reimar Wernich, Lambertsen, Lotte Munch, Andersen, Christian Østergaard, Knudsen, Inge Jenny Dahl, Thomsen Lotte Lambertsen, Christian Østergaard, Marlene Skovgaard, Henrik Carl Schønheyder, Konradsen, Helle Bossen, Thomsen, Reimar Wernich, Lotte Lambertsen, Ostergaard, Christian, Slotved, Hans-Christian, Jenny Dahl Knudsen, Jette Bangsborg, Hans-Christian Slotved, Knudsen, Jenny Dahl, Benfield, Thomas, Thomsen Reimar Wernich, Bangsborg Jette, Skovgaard Marlene, Østergaard Christian, Schønheyder Henrik Carl, Konradsen Helle Bossen, Knudsen Jenny Dahl, Benfield Thomas, Slotved Hans-Christian, Lambertsen Lotte   +34 more
core   +1 more source

Vaccination against pneumococcus in West Africa: perspectives and prospects

International Journal of General Medicine, 2013
Eric S Donkor,1 Nicholas TKD Dayie,1,2 Ebenezer V Badoe3 1Department of Microbiology, University of Ghana Medical School, Accra, Ghana; 2Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen ...
Donkor ES, Dayie NT, Badoe EV
doaj  

The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on serotype 19A invasive pneumococcal disease

, 2015
The circulation in the community of pneumococcal serotype 19A, a highly invasive and frequently extremely resistant pneumococcal strain, has increased the focus on methods to control its presence and effect.
Esposito, Susanna Maria Roberta, S. Esposito, N. Principi   +2 more
core   +1 more source

Pneumococcal conjugate vaccines—a European perspective

International Journal of Medical Microbiology, 2004
Streptococcus pneumoniae is a leading cause of bacterial pneumonia, meningitis, and acute otitis media in children and adults worldwide. In the age group of < 2 years the incidence of invasive pneumococcal disease ranges from approximately 14 cases per 100,000 in Germany and the Netherlands and more than 90 per 100,000 children in Spain.
openaire   +2 more sources

Recent Advances in Pneumococcal Conjugate Vaccines: A 13-Valent Pneumococcal Conjugate Vaccine

Journal of Pediatric Infection, 2011
Streptococcus pneumoniae (pneumococcus) is an important cause of serious infectious diseases, leading to death among children all over the world. The 7-valent pneumococcal conjugate vaccine (PCV7), which was introduced in 2000 to prevent pneumococcal infections, was included in the Childhood National Immunization Program of Turkey in November 2008 and ...
openaire   +2 more sources